Pablo Mando/X
May 18, 2025, 09:26
Pablo Mando Shares Insights on Biomarkers in Antibody–Drug Conjugates
Pablo Mando, Editor-in-Chief of Oncologia Clínica, shared a post on X:
“Take home messages of a comprehensive overview on response and toxicity prediction biomarkers in ADC
Few currently available biomarkers to guide selection
A growing list of potential markers
Need of Mechanisms to Discover and Validate biomarkers.”
Find More Posts Featuring Pablo Mando on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jul 21, 2025, 10:57
Jul 21, 2025, 10:44
Jul 21, 2025, 10:24
Jul 21, 2025, 10:13
Jul 20, 2025, 20:20
Jul 20, 2025, 20:10